INSIGHTS ON CLINICAL TRIAL DESIGN
-
![Doctor talking to patient-GettyImages-1330555438]( "Driving Diversification And Reach With Tech In Community DCTs")
Driving Diversification And Reach With Tech In Community DCTsLearn how technology, when used correctly, can accelerate trial timelines and drive patient diversification in community-based decentralized clinical trials (DCTs).
-
![Nurse and oncology patients-GettyImages-1480325057]( "The Growing Complexity Of Conducting Oncology Trials")
The Growing Complexity Of Conducting Oncology TrialsAs diversity plans and multi-regional considerations become core to trial design, early-phase oncology programs must navigate a landscape that offers unprecedented opportunity.
-
![Business Meeting-GettyImages-1831418247]( "Accelerate Drug Development With Master Protocols")
Accelerate Drug Development With Master ProtocolsThrough careful planning, aligned incentives, and an open, adaptive mindset, master protocols become powerful engines for accelerating therapies to market—particularly in high-need therapeutic areas.
-
![20 20 onsite]( "Clinical Research Logistics: How Point-Of-Need Execution Protects Ocular Endpoints")
Clinical Research Logistics: How Point-Of-Need Execution Protects Ocular EndpointsReduce operational risk in ophthalmic trials with point-of-need execution. Discover how mobile clinics, specialized teams, and single-call accountability protect endpoint quality and study timelines.
-
Navigating The Challenges Of Large, International Phase III Breast Cancer Trials5/27/2026
In the competitive landscape of breast cancer research, aligning biomarker testing, regulatory pathways, and regional operations from day one creates a path to faster enrollment and stronger outcomes.
-
Rewriting Cancer: Advancing Patient Access, Together6/23/2026
Rewriting Cancer puts a spotlight on the push to connect more patients to clinical trials and how data, technology, and lived experience can help expand access to life-changing care.
-
DCTs And Community-Based Research Execution And Compliance5/28/2025
The FDA's regulatory endorsement of DCTs enhances their credibility, offering a pathway to more inclusive and accessible clinical research that benefits both patients and sponsors.
-
How Modern RTSM Platforms Are Eliminating Delays2/25/2026
Stop letting rigid legacy RTSM systems stall your clinical trials. Learn why manual change requests cause months of delays and how a modern, platform-based approach restores your study’s agility.
-
Making Early Decisions In Psychiatric Drug Development7/30/2026
Quantitative PD measures provide objective evidence of target engagement, support dose selection, strengthen early go/no-go decisions, and help reduce development risk in psychiatric
CLINICAL TRIAL DESIGN SOLUTIONS
-
![GettyImages-2148023123-oncology-patient-appointment]( "Ready To Reach Proof Of Concept Faster?")
Proof-of-concept provides a critical bridge between Phase 1 and Phase 2 trials, making an experienced CRO partner vital to achieving optimal outcomes for early-phase clinical research.
-
![GettyImages-1311429557-vaccine-shot]( "The #1 Rated Leader In DCT Now Offers The Vaccine Pathway")
Explore an expertly crafted package of programs, products, and expertise addressing the unique challenges of vaccine research.
-
![GettyImages-1302454470 drug review]( "Why Central IRBs Matter For Efficient Clinical Trials")
“Going the extra mile is a big part of our DNA. Personal attention can go a long way in ensuring the success of your next research study.”
Raffaella Hart, MS, CIP
Sr. Vice President, IRB and IBC ServicesFast, reliable IRB review for multisite studies backed by expert oversight and responsive support. With streamlined submissions, frequent meetings, and dedicated client managers, BRANY IRB helps you save time and money while maintaining full regulatory compliance.
-
![Cloud computing digita-GettyImages-2161057424]( "Unify Workflows And Accelerate Execution From Protocol To Submission")
Explore a platform that benefits the entire global clinical trial ecosystem by reducing complexity and operational costs while maintaining the highest standards of data security and subject privacy.
-
![GettyImages-2081140990-phone-cellphone-hand]( "Visit Management Solution Built For Global Trials")
From reminders to resource coordination, visit scheduling shouldn't slow trials down. Discover how automation can reduce deviations and support participants.
